When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CARA - Cara Therapeutics Is An Undervalued Asset In 2020
Cara Therapeutics Inc.
Today, we will be studying why Cara Therapeutics (CARA) is an attractive investment for 2020.
Company overview
Cara Therapeutics is a clinical-stage company focused on the development of peripheral KORs (kappa opioid receptors). The company’s lead investigational product and first-in-class KOR, Korsuva, is being explored as an injectable as well as an oral therapy for pruritus in various settings. The company has also completed a Phase 2/3 trial for Korsuva intravenous therapy in pain indication.
How do KORs work?
Four types of opioid receptors, mu, delta, kappa, and opioid-receptor like-1, play a